Amphastar Pharmaceuticals, Inc.
AMPH
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary rā¦ read more
Healthcare
Drug ManufacturersāSpecialty & Generic
10 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$23.86
Price+1.49%
$0.35
1Y
Price
Market Cap
$1.109b
Small
Price/Earnings 3y Avg5y Avg
8.9x
Premium
Premium
Financials Overview
Key metrics over the past few years+36.1%
EBITDA Margin+25.1%
Net Profit Margin+27.1%
Free Cash Flow MarginRevenue
$720.284m
+4.9%
1y CAGR+16.0%
3y CAGR+18.3%
5y CAGREarnings
$134.708m
+12.5%
1y CAGR+36.7%
3y CAGR+1418.1%
5y CAGREPS
$2.67
+11.2%
1y CAGR+33.3%
3y CAGR+1562.5%
5y CAGRBook Value
$757.482m
$1.615b
Assets$857.851m
Liabilities$47.770m
DebtDebt to Assets
3.0%
2.6x
Debt to EBITDAFree Cash Flow
$112.189m
+10.7%
1y CAGR+42.1%
3y CAGR+81.9%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company